WOOJUNG BIO Inc
WOOJUNG BIO, Inc. provides non-clinical research agency services. The company was founded in 1989 and is based in Hwaseong-si, South Korea.
WOOJUNG BIO Inc (215380) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.033x
Based on the latest financial reports, WOOJUNG BIO Inc (215380) has a cash flow conversion efficiency ratio of -0.033x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-809.75 Million) by net assets (₩24.58 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
WOOJUNG BIO Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how WOOJUNG BIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
WOOJUNG BIO Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of WOOJUNG BIO Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Impulse Fitness Solutions SA
PA:MLIFS
|
N/A |
|
Hipay Group SA
PA:ALHYP
|
0.066x |
|
Birla Cable Limited
NSE:BIRLACABLE
|
-0.019x |
|
Trigg Minerals Limited
OTCQB:TMGLF
|
-0.947x |
|
Haesung Optics Co. Ltd
KQ:076610
|
-0.340x |
|
Eutilex.Co.Ltd
KQ:263050
|
-0.083x |
|
Enimmune corporation
TWO:6564
|
-0.450x |
|
BEGHELLI S.P.A. EO -05
F:BGQ
|
N/A |
Annual Cash Flow Conversion Efficiency for WOOJUNG BIO Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of WOOJUNG BIO Inc from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩29.37 Billion | ₩-1.13 Billion | -0.038x | +73.85% |
| 2023-12-31 | ₩21.97 Billion | ₩-3.22 Billion | -0.147x | -274.16% |
| 2022-12-31 | ₩29.72 Billion | ₩2.50 Billion | 0.084x | +53.31% |
| 2021-12-31 | ₩31.46 Billion | ₩1.73 Billion | 0.055x | +117.95% |
| 2020-12-31 | ₩28.03 Billion | ₩-8.57 Billion | -0.306x | -4007.26% |
| 2019-12-31 | ₩26.66 Billion | ₩208.72 Million | 0.008x | +134.30% |
| 2018-12-31 | ₩21.20 Billion | ₩-483.80 Million | -0.023x | +82.39% |
| 2017-12-31 | ₩18.32 Billion | ₩-2.38 Billion | -0.130x | +5.85% |
| 2016-12-31 | ₩10.57 Billion | ₩-1.46 Billion | -0.138x | -- |